Longboard Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Good morning, everyone. So it's the third day of the 2023 Cantor Global Healthcare Conference. And I'm really excited to be here, not only because it's been a couple of long days, but because there are some very interesting companies that we're going to be talking about today. And the first is Longboard Pharmaceuticals. So I have Kevin Lind, the company's President and CEO from Longboard. Kevin? Good to see you.
Good to see you.
It's a company we cover and a very exciting company for its history, but also where it's going and how it can transform with a best-in-class drug for epilepsy. So Kevin's going to run through a few slides, we'll stop him, I'll interrupt him, ask him a few questions. If the audience has any questions, please yell out at me, and then we'll carry on. Kevin?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
